The overall objective of this proposal is to conduct a longitudinal prospective study of healthy pregnant women and their offspring to determine which antenatal maternal exercise mode(s) will have the greatest impact on maternal and infant cardiometabolic health. This information may lead to modified clinical practice recommendations that improve health in childhood and possibly beyond. This randomized controlled trial will recruit 268 healthy pregnant women randomized to an exercise intervention (aerobic exercise, resistance exercise, aerobic and resistance exercise) or to no exercise (usual care); their infants will be measured at 1, 6, and 12 months of age. This rigorous design will test our central hypothesis that aerobic and resistance exercise and resistance exercise training during pregnancy will, in healthy weight BMI (HW) women, improve maternal and offspring cardiometabolic outcomes to a greater extent than AE alone. This study will test this hypothesis with two specific aims: Aim 1. Determine the influence of different exercise modes during HW pregnancy on infant cardiometabolic health and growth trajectories. Hypothesis: AE, RE, and AERE by HW pregnant women will improve offspring neuromotor and cardiometabolic measures at 1, 6, and 12 months postpartum (e.g. decreased % body fat, BMI z-score, heart rate, non-HDL, and C-Reactive Protein (CRP); increased insulin sensitivity) compared to infants of HW pregnant women that do not exercise; AERE and RE will have the greatest impact on improving infant measures. Aim 2. Determine the most effective exercise mode in HW pregnancy on improving maternal cardiometabolic health outcomes. Hypothesis: AE, RE, and AERE by HW pregnant women will improve both maternal cardiometabolic health measures (e.g. decreased BMI z-score, non-HDL, % body fat, HR, weight gain) across pregnancy (16 to 36 weeks gestation) and overall pregnancy outcomes (e.g. lower incidence of gestational diabetes, pre-eclampsia, hypertension during gestation) compared to HW pregnant women that do not exercise; AERE and RE will have the greatest impact on improving maternal health measures, with the AERE group having the highest compliance. The proposed innovative study will be the first to provide a critical understanding of the influence of antenatal exercise modes upon the cardiometabolic health and growth trajectories of offspring who may be at increased risk of poor outcomes. This work will have a significant impact on reducing the cycle of OB and CVD, potentially providing the earliest and most efficacious intervention to attenuate or prevent OB and CVD in the next generation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
268
Moderate intensity aerobic exercise, moderate intensity resistance exercise, moderate intensity combination exercise
East Carolina University
Greenville, North Carolina, United States
RECRUITING1 month Infant non-HDL
non-HDL measures from venipuncture
Time frame: 1 month
6 month Infant non-HDL
non-HDL measures from venipuncture
Time frame: 6 months
12 month Infant non-HDL
non-HDL measures from venipuncture
Time frame: 12 months
1 month infant BMI z-score
BMI normalized
Time frame: 1 month
6 month infant BMI z-score
BMI normalized
Time frame: 6 months
12 month infant BMI z-score
BMI normalized
Time frame: 12 months
Enrollment (8-13wks) Maternal fasting non-HDL
non-HDL measured from venipuncture
Time frame: enrollment (~8-13 wks gestation)
36wk Maternal fasting non-HDL
non-HDL measured from venipuncture
Time frame: 36wks gestation
1 month Maternal fasting non-HDL
non-HDL measured from venipuncture
Time frame: 1 month postpartum
6 month Maternal fasting non-HDL
non-HDL measured from venipuncture
Time frame: 6 months postpartum
Adverse Pregnancy Outcomes
Presence or absence of Adverse Pregnancy outcomes (preterm birth, gestational diabetes \[GDM\], preeclampsia, hypertension)
Time frame: At delivery
12 month Maternal fasting non-HDL
non-HDL measured from venipuncture
Time frame: 12 months postpartum
1 month infant Resting Heart Rate
resting HR
Time frame: 1 month
6 month infant Resting Heart Rate
resting HR
Time frame: 6 months
12 month infant Resting Heart Rate
resting HR
Time frame: 12 months
1 month infant Resting Blood Pressure
resting BP
Time frame: 1 month
6 month infant Resting Blood Pressure
resting BP
Time frame: 6 months
12 month infant Resting Blood Pressure
resting BP
Time frame: 12 months
1 month infant Body Fat %
body fat % from skinfolds
Time frame: 1 month
6 month infant Body Fat %
body fat % from skinfolds
Time frame: 6 months
12 month infant Body Fat %
body fat % from skinfolds
Time frame: 12 months
1 month infant % Muscle Mass
muscle mass % from skinfolds
Time frame: 1 month
6 month infant % Muscle Mass
muscle mass % from skinfolds
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
12 month infant % Muscle Mass
muscle mass % from skinfolds
Time frame: 12 months
1 month Infant Resting Energy Expenditure (REE)
resting REE
Time frame: 1 month
6 month Infant Resting Energy Expenditure (REE)
resting REE
Time frame: 6 months
12 month Infant Resting Energy Expenditure (REE)
resting REE
Time frame: 12 months
1 month Infant Neuromotor Assessment
Peabody Developmental Motor Scale (1st - 99th percentile) - the higher the percentile the better
Time frame: 1 month
6 month Infant Neuromotor Assessment
Peabody Developmental Motor Scale (1st - 99th percentile) - the higher the percentile the better
Time frame: 6 months
12 month Infant Neuromotor Assessment
Peabody Developmental Motor Scale (1st - 99th percentile) - the higher the percentile the better
Time frame: 12 months
1 month Infant Veggie Meter
Raman Spectroscopy-Skin Carotenoid assessments
Time frame: 1 month
6 month Infant Veggie Meter
Raman Spectroscopy-Skin Carotenoid assessments
Time frame: 6 months
12 month Infant Veggie Meter
Raman Spectroscopy-Skin Carotenoid assessments
Time frame: 12 months
1 month Infant Blood Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 1 month
6 month Infant Blood Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 6 months
12 month Infant Blood Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 12 months
1 month Infant Blood Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 1 month
6 month Infant Blood Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 6 months
12 month Infant Blood Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 12 months
1 month Infant Blood Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 1 month
6 month Infant Blood Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 6 months
12 month Infant Blood Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 12 months
1 month Infant Metabolomics
Metabolomic pathway analysis of significantly different blood metabolites based on p-value less than or equal to 0.05
Time frame: 1 month
6 month Infant Metabolomics
Metabolomic pathway analysis of significantly different blood metabolites based on p-value less than or equal to 0.05
Time frame: 6 months
12 month Infant Metabolomics
Metabolomic pathway analysis of significantly different blood metabolites based on p-value less than or equal to 0.05
Time frame: 12 months
16wk Maternal Resting Heart Rate
resting HR
Time frame: 16wks gestation
36wk Maternal Resting Heart Rate
resting HR
Time frame: 36wks gestation
1 month Postpartum Maternal Resting Heart Rate
resting HR
Time frame: 1 month postpartum
6 month Postpartum Maternal Resting Heart Rate
resting HR
Time frame: 6 months postpartum
12 month Postpartum Maternal Resting Heart Rate
resting HR
Time frame: 12 months postpartum
16wk Maternal Resting Blood Pressure
resting BP
Time frame: 16wks gestation
36wk Maternal Resting Blood Pressure
resting BP
Time frame: 36wks gestation
1 month Postpartum Maternal Resting Blood Pressure
resting BP
Time frame: 1 month postpartum
6 month Postpartum Maternal Resting Blood Pressure
resting BP
Time frame: 6 months postpartum
12 month Postpartum Maternal Resting Blood Pressure
resting BP
Time frame: 12 months postpartum
Maternal Gestational Weight Gain (GWG)
Gestational Weight Gain
Time frame: At delivery
16wk Maternal Body Fat %
estimated body fat %
Time frame: 16wks gestation
36wk Maternal Body Fat %
estimated body fat %
Time frame: 36wks gestation
1 month Postpartum Maternal Body Fat %
estimated body fat %
Time frame: 1 month postpartum
6 month Postpartum Maternal Body Fat %
estimated body fat %
Time frame: 6 months postpartum
12 month Postpartum Maternal Body Fat %
estimated body fat %
Time frame: 12 months postpartum
16wk Maternal Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 16wks gestation
36wk Maternal Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 36wks gestation
1 month Postpartum Maternal Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 1 month postpartum
6 month Postpartum Maternal Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 6 months postpartum
12 month Postpartum Maternal Biomarkers (CRP)
Multiplex analyses of inflammatory markers (CRP)
Time frame: 12 months postpartum
16wk Maternal Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 16wks gestation
36wk Maternal Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 36wks gestation
1 month Postpartum Maternal Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 1 month postpartum
6 month Postpartum Maternal Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 6 months postpartum
12 month Postpartum Maternal Biomarkers (IL6)
Multiplex analyses of inflammatory markers (IL6)
Time frame: 12 months postpartum
16wks Maternal Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 16wks gestation
36wks Maternal Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 36wks gestation
1 month postpartum Maternal Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 1 month postpartum
6 month postpartum Maternal Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 6 months postpartum
12 month postpartum Maternal Biomarkers (adiponectin)
Multiplex analyses of inflammatory markers (adiponectin)
Time frame: 12 months postpartum
16wks Maternal Biomarkers (cortisol)
Multiplex analyses of inflammatory markers (cortisol)
Time frame: 16wks gestation
36wks Maternal Biomarkers (cortisol)
Multiplex analyses of inflammatory markers (cortisol)
Time frame: 36wks gestation
1 month Postpartum Maternal Biomarkers (cortisol)
Multiplex analyses of inflammatory markers (cortisol)
Time frame: 1 month postpartum
6 month Postpartum Maternal Biomarkers (cortisol)
Multiplex analyses of inflammatory markers (cortisol)
Time frame: 6 months postpartum
12 month Postpartum Maternal Biomarkers (cortisol)
Multiplex analyses of inflammatory markers (cortisol)
Time frame: 12 months postpartum